In this context, a new generation of QFN called QFN-Plus has incorporated new peptides able to induce IFN-γ responses on CD4+ and CD8+ T-cells, trying to increase the accuracy of the assay and to correlate T-cell responses with antigen load or high risk of TB progression (29). This evidence concerns the gene CD8A and tuberculosis.